UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

COVID-19: the new challenge for rheumatologists

Clinical and Experimental Rheumatology, 2020-03, Vol.38 (2), p.175-180

2020

Volltextzugriff (PDF)

The patient’s perspective: are quality of life and disease burden a possible treatment target in systemic lupus erythematosus?

Rheumatology (Oxford, England), 2020-12, Vol.59 (Supplement_5), p.v63-v68

2020

Volltextzugriff (PDF)

Articular involvement, steroid treatment and fibromyalgia are the main determinants of patient-physician discordance in systemic lupus erythematosus

Arthritis research & therapy, 2020-10, Vol.22 (1), p.1-241, Article 241

2020

Volltextzugriff (PDF)

Impact of first wave of SARS-CoV-2 infection in patients with Systemic Lupus Erythematosus: Weighting the risk of infection and flare

PloS one, 2021-01, Vol.16 (1), p.e0245274-e0245274

2021

Volltextzugriff (PDF)

Baricitinib and Pulse Steroids Combination Treatment in Hyperinflammatory COVID-19: A Rheumatological Approach in the Intensive Care Unit

International journal of molecular sciences, 2024-07, Vol.25 (13), p.7273

2024

Volltextzugriff (PDF)

Treat-to-Target in Systemic Lupus Erythematosus: Reality or Pipe Dream

Journal of clinical medicine, 2023-05, Vol.12 (9), p.3348

2023

Volltextzugriff (PDF)

Glucocorticoid withdrawal in systemic lupus erythematosus: are remission and low disease activity reliable starting points for stopping treatment? A real-life experience

Rheumatic & musculoskeletal diseases open, 2019-06, Vol.5 (2), p.e000916-e000916

2019

Volltextzugriff (PDF)

Salivary Proteomics Markers for Preclinical Sjögren’s Syndrome: A Pilot Study

Biomolecules (Basel, Switzerland), 2022-05, Vol.12 (6), p.738

2022

Volltextzugriff (PDF)

Impact of disease activity patterns on health-related quality of life (HRQoL) in patients with systemic lupus erythematosus (SLE)

Lupus science & medicine, 2024-07, Vol.11 (2), p.e001202

2024

Volltextzugriff (PDF)

When is the right time to change therapy? An observational study of the time to response to immunosuppressive drugs in systemic lupus erythematosus

Lupus science & medicine, 2024-07, Vol.11 (2), p.e001207

2024

Volltextzugriff (PDF)

Gender differences in SLE: report from a cohort of 417 Caucasian patients

Lupus science & medicine, 2023-04, Vol.10 (1), p.e000880

2023

Volltextzugriff (PDF)

Interstitial Lung Disease Phenotypes and Predictive Risk Factors in Primary Sjögren’s Syndrome

Journal of clinical medicine, 2024-08, Vol.13 (16), p.4963

2024

Volltextzugriff (PDF)

Primary-Sjögren's-Syndrome-Related Interstitial Lung Disease: A Clinical Review Discussing Current Controversies

Journal of clinical medicine, 2023-05, Vol.12 (10), p.3428

2023

Volltextzugriff (PDF)

Disease evolution and organ damage accrual in patients with stable UCTD: a long-term monocentric inception cohort

Rheumatic & musculoskeletal diseases open, 2024-04, Vol.10 (2), p.e003967

2024

Volltextzugriff (PDF)

Analysis of belimumab prescription and outcomes in a 10-year monocentric cohort: is there an advantage with early use?

Rheumatic & musculoskeletal diseases open, 2024-04, Vol.10 (2), p.e003981

2024

Volltextzugriff (PDF)

P122 Skin disease burden in systemic lupus erythematosus: data from a monocentric cohort

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A127-A128

2024

Volltextzugriff (PDF)

Impact of fatigue on health-related quality of life and illness perception in a monocentric cohort of patients with systemic lupus erythematosus

Rheumatic & musculoskeletal diseases open, 2020-02, Vol.6 (1), p.e001133

2020

Volltextzugriff (PDF)

Impact of low-dose acetylsalicylic acid on pregnancy outcome in systemic lupus erythematosus: results from a multicentre study

Lupus science & medicine, 2022-06, Vol.9 (1), p.e000714

2022

Volltextzugriff (PDF)

One year in review 2022: systemic lupus erythematosus

Clinical and Experimental Rheumatology, 2022-01, Vol.40 (1), p.4-14

2022

Volltextzugriff (PDF)

The communication GAP between patients and clinicians and the importance of patient reported outcomes in Systemic Lupus Erythematosus

Best practice & research. Clinical rheumatology, 2023-12, Vol.37 (4), p.101939, Article 101939

2023

Volltextzugriff (PDF)

Treatment With Anifrolumab for Discoid Lupus Erythematosus

JAMA dermatology (Chicago, Ill.), 2023-02, Vol.159 (2), p.224

2023

Volltextzugriff (PDF)

One year in review 2017: novelties in the treatment of rheumatoid arthritis

Clinical and experimental rheumatology, 2017-09, Vol.35 (5), p.721

2017

Volltextzugriff (PDF)

Biomarkers for Sjögren's syndrome

Biomarkers in medicine, 2018-03, Vol.12 (3), p.275-286

2018

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(78)
Bücher
(2)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(71)
Life Sciences & Biomedicine
(70)
Humans
(50)
Rheumatology
(46)
Lupus
(17)
Systemic Lupus Erythematosus
(17)
Male
(16)
Patients
(16)
Female
(15)
Adult
(14)
Lupus Erythematosus, Systemic - Drug Therapy
(11)
Middle Aged
(11)
Quality Of Life
(11)
Magnetic Resonance Imaging
(10)
Retrospective Studies
(10)
Autoimmune Diseases
(9)
Lupus Erythematosus, Systemic - Complications
(8)
Neurosciences & Neurology
(8)
Treatment
(8)
Arthritis
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

COVID-19: the new challenge for rheumatologists

The patient’s perspective: are quality of life and disease burden a possible treatment target in systemic lupus erythematosus?

Articular involvement, steroid treatment and fibromyalgia are the main determinants of patient-physician discordance in systemic lupus erythematosus

Impact of first wave of SARS-CoV-2 infection in patients with Systemic Lupus Erythematosus: Weighting the risk of infection and flare

Baricitinib and Pulse Steroids Combination Treatment in Hyperinflammatory COVID-19: A Rheumatological Approach in the Intensive Care Unit

Treat-to-Target in Systemic Lupus Erythematosus: Reality or Pipe Dream

Glucocorticoid withdrawal in systemic lupus erythematosus: are remission and low disease activity reliable starting points for stopping treatment? A real-life experience

Salivary Proteomics Markers for Preclinical Sjögren’s Syndrome: A Pilot Study

Impact of disease activity patterns on health-related quality of life (HRQoL) in patients with systemic lupus erythematosus (SLE)

When is the right time to change therapy? An observational study of the time to response to immunosuppressive drugs in systemic lupus erythematosus

Gender differences in SLE: report from a cohort of 417 Caucasian patients

Interstitial Lung Disease Phenotypes and Predictive Risk Factors in Primary Sjögren’s Syndrome

Primary-Sjögren's-Syndrome-Related Interstitial Lung Disease: A Clinical Review Discussing Current Controversies

Disease evolution and organ damage accrual in patients with stable UCTD: a long-term monocentric inception cohort

Analysis of belimumab prescription and outcomes in a 10-year monocentric cohort: is there an advantage with early use?

P122 Skin disease burden in systemic lupus erythematosus: data from a monocentric cohort

Impact of fatigue on health-related quality of life and illness perception in a monocentric cohort of patients with systemic lupus erythematosus

First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry)

Impact of low-dose acetylsalicylic acid on pregnancy outcome in systemic lupus erythematosus: results from a multicentre study

Efficacy of pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases

One year in review 2022: systemic lupus erythematosus

The communication GAP between patients and clinicians and the importance of patient reported outcomes in Systemic Lupus Erythematosus

Treatment With Anifrolumab for Discoid Lupus Erythematosus

One year in review 2017: novelties in the treatment of rheumatoid arthritis

Biomarkers for Sjögren's syndrome

Suchergebnisse filtern